Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

por Boekel, Laura, Hooijberg, Femke, Vogelzang, Erik H, Besten, Yaëlle R, Leeuw, Maureen, Atiqi, Sadaf, van Vollenhoven, Ronald F, Wijbrandts, Carla A, Gerritsen, Martijn, Krieckaert, C, Dijkshoorn, Bas, Bakhlakh, Siham, Crooijmans, Juliette J, Voskuyl, Alexandre, van der Horst-Bruinsma, Irene E, Lems, Willem, Kuijpers, Taco W, van Ham, S Marieke, Wieske, Luuk, Eftimov, Filip, Kummer, Laura Y, van Dam, PJ Koos, Stalman, Eileen W, Steenhuis, Maurice, Keijzer, Sofie, Cristianawati, Olvi, Keijser, Jim, Loeff, Floris C, Tas, Sander W, Nurmohamed, Michael T, Boers, Maarten, Rispens, Theo, Wolbink, Gertjan
Publicado 2022